Notable Analyst Rating Changes 6/4: NBR, MS, TSN Upgraded; MAR, VNUS, OMRI Downgraded
More News related to MAR
- David Moenning's Daily State of the Markets: 7/1
- Hotel Stocks Fall as Barclays Cuts Marriott (MAR), Starwood (HOT), Choice Hotels (CHH) to Underweight
- Barclays Downgrades Marriott (MAR) to Underweight
- Marriott Becomes the Largest Hotel Company to Offer Telepresence Globally, Giving Customers the Widest Array of Meeting Options
- Marriott to Offer Telepresence Worldwide, Giving Customers the Widest Array of Meeting Options
More News related to MS
- Goodrich Petroleum to Present at Morgan Stanley Energy Conference
- Oceaneering to Present at the Morgan Stanley Energy Conference
- David Moenning's Daily State of the Markets: 7/1
- MUFG and Morgan Stanley Announce New Agreements to Strengthen Global Alliance
- Wall Street Firms Have Best Quarter Since Crisis (JPM, GS, MS, BAC)
More News related to NBR
- Goldman Sachs Upgrades a Number of Oil Stocks (CAM, RIG, DO, FTI)
- Nabors Industries Ltd. Second Quarter 2009 Earnings Conference Call Invitation
- Nabors Industries (NBR) Announces Management Realignment of Nabors Well Services Ltd.
- Nabors Announces Realignment of Nabors Well Services Ltd. Management
- David Moenning's Daily State of the Markets: 5/8
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Goldman Sachs upgrades Nabors (NYSE: NBR) from Neutral to Buy.
Wachovia upgrades Morgan Stanley (NYSE: MS) to Outperform and sets a valuation range of $51-$53, which is based on 1.7x the firm's estimated Q208 book value.
Wachovia upgrades Tyson Foods (NYSE: TSN) from Market Perform to Outperform with a $24 to $26 valuation range.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Piper Jaffray downgrades VNUS Medical (NASDAQ: VNUS) from Buy to Neutral and raises their price target from $20 to $21.
UBS downgrades Omrix Biopharmaceuticals (Nasdaq: OMRI) from Buy to Neutral. Price target $17.
Oppenheimer downgrades Marriott International (NYSE: MAR) from Outperform to Perform with a $35 price target, saying headwinds including A weak leisure and business travel market and limited exposure to high growth international markets suggest shares could be range bound.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Merrill Lynch initiates coverage on Sherwin Williams (NYSE: SHW) with an Underperform rating, following yesterday's profit warning from the company.
Goldman Sachs initiates coverage on Xenoport, Inc. (Nasdaq: XNPT) with a Buy rating and $60 price target.
Baird initiates coverage on VF Corporation (NYSE: VFC) with an Outperform, citing strong (long-term) growth outlook. Price target $90.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+6.34
-3.31Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
